Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial - The Lancet

Oral Antihypertensives for Management of Severe Hypertension in Pregnancy - American College of Cardiology

Management of Hypertension in Pregnancy

Hypertensive Disorders in Pregnancy and Eclampsia (Chapter 25) - The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology

The Lancet on X: NEW Research—Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe #hypertension in #pregnancy: an open-label, randomised controlled trial

PDF) Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open- label, randomised controlled trial

Effectiveness of nifedipine, labetalol, and

IJERPH, Free Full-Text

PDF) Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open- label, randomised controlled trial

Oral labetalol versus oral nifedipine for the management of postpartum hypertension a randomized control trial. - Abstract - Europe PMC

Labetalol (AH5158), α1/β-adrenergic Receptors Antagonist

Management of Hypertension in Pregnancy

Endometriosis does not seem to be an influencing factor of hypertensive disorders of pregnancy in IVF / ICSI cycles, Reproductive Biology and Endocrinology